Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past

D Giannis, IA Ziogas, P Gianni - Journal of Clinical Virology, 2020 - Elsevier
… Preliminary reports on COVID-19 patients’ clinical and laboratory findings include … disorders
in COVID-19 infected patients and review relevant data of previous coronavirus epidemics …

[HTML][HTML] Characteristics of SARS-CoV-2 and COVID-19

B Hu, H Guo, P Zhou, ZL Shi - Nature reviews microbiology, 2021 - nature.com
… In non-human primate animal models, most species display clinical features similar to those
of patients with COVID-19, including virus shedding, virus replication and host responses to …

[HTML][HTML] Neurological manifestations of COVID-19 (SARS-CoV-2): a review

MU Ahmed, M Hanif, MJ Ali, MA Haider… - Frontiers in …, 2020 - frontiersin.org
… Physicians should be cognizant of these manifestations while dealing COVID-19 patients. …
, SARS-CoV-2 can also have neurotropic effects because many COVID 19 patients present …

[HTML][HTML] Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals

L Ni, F Ye, ML Cheng, Y Feng, YQ Deng, H Zhao… - Immunity, 2020 - cell.com
… to SARS-CoV-2 infection. Here, we collected blood from COVID-19 patients who have
recently become virus-free, and therefore were discharged, and detected SARS-CoV-2-specific …

[HTML][HTML] Recurrence of positive SARSCoV‐2 in patients recovered from COVID19

VT Hoang, TL Dao, P Gautret - Journal of medical virology, 2020 - ncbi.nlm.nih.gov
… info/coronavirus/). The currently recommended medical observation period or … for COVID19
patients is 14 days. According to the WHO's guidelines on clinical management, a patient

Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak

M Dai, D Liu, M Liu, F Zhou, G Li, Z Chen, Z Zhang… - Cancer discovery, 2020 - AACR
… with cancer and 536 age-matched noncancer patients confirmed with COVID-19. Our results
showed COVID-19 patients with cancer had higher risks in all severe outcomes. Patients

The presence of SARSCoV‐2 RNA in the feces of COVID19 patients

Y Chen, L Chen, Q Deng, G Zhang, K Wu… - Journal of medical …, 2020 - Wiley Online Library
SARS-CoV-2 has not been fully understood. In this study, we aimed to investigate SARS-CoV-2
shedding in the excreta of COVID-19 patients… findings of enrolled patients were extracted …

[HTML][HTML] Viable SARS-CoV-2 in various specimens from COVID-19 patients

HW Jeong, SM Kim, HS Kim, YI Kim, JH Kim… - Clinical Microbiology …, 2020 - Elsevier
… However, despite several attempts [[18], [19], [20]], only one study thus far has demonstrated
the presence of the infectious virus in faecal specimens from COVID-19 patients during the …

Scientific research progress of COVID19/SARSCoV‐2 in the first five months

H Li, Z Liu, J Ge - Journal of cellular and molecular medicine, 2020 - Wiley Online Library
… According to a survey conducted by Chinese Centers for Disease Control and Prevention
on more than 40,000 COVID-19 patients, about 56% of the patients were men and the median …

Absence of SARSCoV‐2 in semen of a COVID19 patient cohort

L Guo, S Zhao, W Li, Y Wang, L Li, S Jiang, W Ren… - …, 2021 - Wiley Online Library
… Twenty-three patients with COVID-19 were enrolled in this … most of these patients have entered
the recovery period of COVID-19, we … or virus-induced autoimmune response in the testis. …